{"id":"https://openalex.org/W1973298751","doi":"https://doi.org/10.1002/hep.26155","title":"Fibrates as adjuvant therapy for chronic cholestatic liver disease: Its time has come","display_name":"Fibrates as adjuvant therapy for chronic cholestatic liver disease: Its time has come","alternate_titles":[],"publication_year":2012,"publication_date":"2012-11-23","ids":{"openalex":"https://openalex.org/W1973298751","doi":"https://doi.org/10.1002/hep.26155","mag":"1973298751","pmid":"https://pubmed.ncbi.nlm.nih.gov/23174993","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4048949"},"language":"en","primary_location":{"id":"doi:10.1002/hep.26155","doi":"https://doi.org/10.1002/hep.26155","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.26155","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26155","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973298751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26155","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081847615","display_name":"Nisanne S. Ghonem","orcid":"https://orcid.org/0000-0002-4724-0576","observed_orcids":["https://orcid.org/0000-0002-4724-0576"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nisanne S. Ghonem","raw_affiliation_strings":["Department of Medicine and Liver Center, Yale University School of Medicine, New Haven, CT","fax: 203-785-7273"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Liver Center, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"fax: 203-785-7273","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048480496","display_name":"James Lorenzen Boyer","orcid":"https://orcid.org/0000-0002-8959-6036","observed_orcids":["https://orcid.org/0000-0002-8959-6036"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L. Boyer","raw_affiliation_strings":["Department of Medicine and Liver Center, Yale University School of Medicine, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Liver Center, Yale University School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081847615"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":2.1287,"has_fulltext":true,"cited_by_count":40,"citation_normalized_percentile":{"value":0.86190755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"57","issue":"5","first_page":"1691","last_page":"1693"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9869999885559082},{"id":"https://openalex.org/keywords/bezafibrate","display_name":"bezafibrate","score":0.9729999899864197},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9150000214576721},{"id":"https://openalex.org/keywords/primary-biliary-cholangitis","display_name":"primary biliary cirrhosis","score":0.875},{"id":"https://openalex.org/keywords/primary-sclerosing-cholangitis","display_name":"primary sclerosing cholangitis","score":1.0},{"id":"https://openalex.org/keywords/cholestatic-liver-disease","display_name":"cholestatic liver disease","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ursodeoxycholic-acid","display_name":"ursodeoxycholic acid","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pregnane-x-receptor","display_name":"pregnane X receptor","score":0.8759999871253967},{"id":"https://openalex.org/keywords/farnesoid-x-receptor","display_name":"farnesoid X receptor","score":0.8550000190734863},{"id":"https://openalex.org/keywords/liver-x-receptor","display_name":"liver X receptor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.7310000061988831},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7414160966873169},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6075646877288818},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.4317222237586975},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42223218083381653},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4164438843727112},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4122960567474365},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3580057919025421},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07242396473884583}],"mesh":[{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001629","descriptor_name":"Bezafibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002756","descriptor_name":"Cholagogues and Choleretics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008105","descriptor_name":"Liver Cirrhosis, Biliary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014580","descriptor_name":"Ursodeoxycholic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/hep.26155","doi":"https://doi.org/10.1002/hep.26155","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.26155","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26155","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"pmid:23174993","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23174993","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology (Baltimore, Md.)","raw_type":"Editorial"},{"id":"pmh:oai:pubmedcentral.nih.gov:4048949","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4048949/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Hepatology","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/hep.26155","doi":"https://doi.org/10.1002/hep.26155","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.26155","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26155","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G411281947","display_name":"Mechanisms of Bile Secretion and Cholestasis","funder_award_id":"R37DK025636","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G9000866473","display_name":"Yale Liver Center","funder_award_id":"P30DK034989","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1973298751.pdf","grobid_xml":"https://content.openalex.org/works/W1973298751.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1527121125","https://openalex.org/W1532206343","https://openalex.org/W1539564928","https://openalex.org/W1559882044","https://openalex.org/W1829697715","https://openalex.org/W1829716012","https://openalex.org/W1963521265","https://openalex.org/W1977666051","https://openalex.org/W1984620293","https://openalex.org/W1987117779","https://openalex.org/W1987652896","https://openalex.org/W1988745496","https://openalex.org/W1995419534","https://openalex.org/W1996562417","https://openalex.org/W1999483773","https://openalex.org/W2028940189","https://openalex.org/W2033362089","https://openalex.org/W2058865320","https://openalex.org/W2059400296","https://openalex.org/W2076982518","https://openalex.org/W2079345345","https://openalex.org/W2083981059","https://openalex.org/W2086263816","https://openalex.org/W2128421518","https://openalex.org/W2146337679","https://openalex.org/W2161816485"],"related_works":["https://openalex.org/W1829716012","https://openalex.org/W2171885360","https://openalex.org/W6910496301","https://openalex.org/W4307845506","https://openalex.org/W4244664910","https://openalex.org/W3158931205","https://openalex.org/W2134238563","https://openalex.org/W2885245587","https://openalex.org/W3135550722","https://openalex.org/W2033362089"],"abstract_inverted_index":{"ABC,":[0],"adenosine-triphosphate\u2013binding":[1,482],"cassette;":[2],"ALP,":[3],"alkaline":[4,60],"phosphatase;":[5],"BF,":[6,655],"bezafibrate;":[7],"CYP,":[8],"cytochrome":[9,701],"P450;":[10],"FDA,":[11],"U.S.":[12,292],"Food":[13,293],"and":[14,98,108,123,139,149,170,224,238,294,304,343,351,370,382,407,418,435,442,465,473,488,503,617,694,707,732,775,788,803,817,844,878,888,923,930,943,960,979,1004,1017,1053],"Drug":[15,295],"Administration;":[16],"FF,":[17],"fenofibrate;":[18],"FXR,":[19,816],"farnesoid":[20,640],"X":[21,25,44,240,641,735],"receptor;":[22,26,37,45],"LXR,":[23],"liver":[24,100,124,261,734,838,1063],"mRNA,":[27],"messenger":[28,704],"RNA;":[29],"PBC,":[30],"primary":[31,39,130,135],"biliary":[32,131,462],"cirrhosis;":[33],"PPAR,":[34,339],"peroxisome":[35,234],"proliferator-activated":[36,235],"PSC,":[38,1005],"sclerosing":[40,136],"cholangitis;":[41],"PXR,":[42,614],"pregnane":[43,239],"TGs,":[46],"triglycerides;":[47],"UDCA,":[48,223,280],"ursodeoxycholic":[49,143],"acid.":[50],"In":[51,364],"1993,":[52],"the":[53,70,85,113,153,160,188,196,270,277,356,365,375,416,420,481,495,528,572,608,619,686,717,733,771,795,829,858,871,912,936,963,982,1025,1048,1059],"effects":[54,417,910,937,1061],"of":[55,72,115,121,156,168,183,191,198,247,279,337,387,409,422,448,471,480,497,531,540,542,555,575,586,607,675,719,722,751,759,766,773,810,821,833,875,897,914,919,928,938,954,965,984,993,1028,1045],"fibrates":[56,88,116,164,250,971,994],"in":[57,117,127,176,187,212,392,429,460,565,588,659,678,836,1000],"lowering":[58],"serum":[59,119,313,461,873],"phosphatase":[61],"(ALP)":[62],"was":[63,499,577,841],"shown":[64],"for":[65,92,258,274,385,981,1036,1058],"bezafibrate":[66],"(BF)":[67],"to":[68,84,142,194,222,286,311,326,397,439,456,522,537,557,621,672,854,882,893,948,1032,1056],"be":[69,90,506,520,740,746],"result":[71,913],"hepatic,":[73],"rather":[74],"than":[75,1021],"bone":[76],"or":[77,134],"intestinal,":[78],"isoenzymes.1":[79],"These":[80,244],"initial":[81],"observations":[82],"led":[83,455],"suggestion":[86],"that":[87,204,228,378,401,513,552,665,688,783,797,831,908,975],"might":[89,560],"beneficial":[91],"patients":[93,128,214,393,523,1001,1037],"with":[94,129,207,215,394,432,451,524,615,624,972,1002,1038],"an":[95,219,426,478,553,763,894],"elevated":[96],"ALP":[97,210,525],"cholestatic":[99,260],"disease.":[101],"Since":[102],"then,":[103],"several":[104,267],"dozen":[105],"case":[106],"reports":[107],"pilot":[109,390],"studies":[110,391,992],"have":[111,561],"demonstrated":[112,400],"efficacy":[114,1035],"reducing":[118],"biomarkers":[120],"cholestasis":[122,587,985],"function":[125],"abnormalities":[126],"cirrhosis":[132],"(PBC)":[133],"cholangitis":[137],"(PSC)":[138],"incomplete":[140,220],"responses":[141],"acid":[144,877,880,887],"(UDCA)":[145],"monotherapy":[146,399],"(Tables":[147],"1":[148],"2).":[150],"Yet,":[151],"despite":[152],"growing":[154],"number":[155],"these":[157,177,199,547,589,679,825,909],"observational":[158],"studies,":[159],"mechanism(s)":[161],"by":[162,595,724,730,748,790,807,824,839,846,917,1010],"which":[163,284,596,612,670,697],"reduce":[165],"biochemical":[166,405,493,584],"markers":[167],"cholestasis,":[169],"whether":[171,955],"fibrate":[172,285],"therapy":[173,206,257,450,564,582],"improves":[174],"survival":[175],"disorders,":[178],"remains":[179],"unclear.":[180],"The":[181],"study":[182,265,511,852,1027],"Honda":[184,411,599,849,1029],"et":[185,412,600,780,850,1030],"al.2":[186],"current":[189],"issue":[190],"HEPATOLOGY":[192],"seeks":[193],"address":[195],"first":[197],"issues.":[200],"Their":[201,1043],"findings":[202],"confirm":[203],"adjunct":[205,256,423],"BF":[208,229,289,299,332,424,452,491,597,616,630,666,689,785,840,898,939,956],"reduces":[209],"levels":[211,761],"adult":[213],"PBC":[216,395,434,1003,1039],"who":[217],"experienced":[218],"response":[221,438,620],"they":[225],"further":[226],"suggest":[227],"acts":[230],"as":[231,255,281,283,307,327,425,467,469,727,729,768,770,970,1006],"a":[232,301,308,328,361,457,605,626,639,691,749,755,791,883,967],"dual":[233,692],"receptor":[236,241,642,736],"(PPAR)":[237],"(PXR)":[242],"agonist.":[243,628],"results":[245],"are":[246,251,374,379,762,800,891,911,997,1013,1050,1054],"interest,":[248],"because":[249,288,571,743],"attracting":[252],"increased":[253,646,915],"attention":[254],"chronic":[259],"diseases.":[262],"Nevertheless,":[263,580],"this":[264,275,566,950],"raises":[266],"questions":[268,953],"regarding":[269],"appropriate":[271],"patient":[272,568],"population":[273],"therapy,":[276],"dosage":[278],"well":[282,468,728,769,1014],"use,":[287],"is":[290,300,360,550,663,690,698,828,867,1019],"not":[291,652,682],"Administration":[296],"(FDA)":[297],"approved.":[298],"fibric-acid":[302,376],"derivative":[303,606],"clinically":[305,383,1016],"used":[306,384],"hypolipidemic":[309],"agent":[310,428],"lower":[312],"triglyceride":[314],"(TG)":[315],"levels,":[316],"primarily":[317],"through":[318],"PPAR":[319,693,725,811],"activation.":[320],"Often,":[321],"it":[322,549],"has":[323],"been":[324],"referred":[325],"\"PPAR-\u03b1\"":[329],"agonist;":[330],"however,":[331,635,904],"activates":[333],"all":[334],"three":[335],"isoforms":[336,726],"human":[338,837],"specifically":[340],"PPAR-\u03b1,":[341],"PPAR-\u03b4,":[342],"PPAR-\u03b3,":[344,815],"at":[345,667,710],"similar":[346,649],"concentrations":[347,874],"(i.e.,":[348],"50,":[349],"20,":[350],"60":[352],"\u03bcM,":[353,669],"respectively).3":[354],"Thus,":[355,685],"term":[357],"\"pan-PPAR\"":[358],"agonist":[359],"more-accurate":[362],"descriptive.":[363],"United":[366],"States,":[367],"fenofibrate":[368],"(FF)":[369],"gemfibrozil,":[371],"PPAR-\u03b1-selective":[372],"agonists,":[373],"derivatives":[377],"FDA":[380],"approved":[381],"treatment":[386,983],"hyperlipidemia.":[388],"Recently,":[389],"refractory":[396],"UDCA":[398,440,498,541,556,996],"FF":[402],"also":[403,645,739,1007],"reduced":[404,786,872],"features":[406],"symptoms":[408],"cholestasis.4-9":[410],"al.":[413,601,781],"currently":[414],"report":[415],"assess":[419],"mechanisms":[421,594,860],"anticholestatic":[427],"19":[430],"adults":[431],"early-stage":[433],"compare":[436],"their":[437],"(600":[441],"10-13":[443,501],"mg/kg/day)":[444],"monotherapy.":[445],"Three":[446],"months":[447],"combination":[449,581],"(400":[453],"mg/day)":[454],"significant":[458],"reduction":[459],"enzymes,":[463],"cholesterol,":[464],"TGs":[466],"modulation":[470],"PPAR-\u03b1":[472,929],"PXR":[474,627,647,660,695,723,744,959],"target":[475],"genes,":[476],"including":[477,753,1024],"up-regulation":[479,832,918],"cassette":[483],"subfamily":[484,921],"G":[485],"transporters,":[486],"ABCG5":[487,834],"ABCG8.":[489],"Although":[490,848,952],"improved":[492,583],"tests,":[494],"dose":[496],"only":[500,533,578],"mg/kg/day":[502,559],"thus":[504],"would":[505,946],"considered":[507],"subtherapeutic.":[508],"A":[509],"recent":[510],"proposes":[512],"candidates":[514],"requiring":[515],"new":[516],"therapeutic":[517,1034],"approaches":[518],"should":[519,738],"limited":[521],">1.5":[526],"times":[527],"upper":[529],"limit":[530],"normal":[532],"after":[534],"incompletely":[535],"responding":[536],"optimal":[538],"doses":[539],"13-15":[543],"mg/kg/day.10":[544],"Based":[545],"on":[546,700,857,899,940,1062],"criteria,":[548],"possible":[551,593],"increase":[554],"15":[558],"provided":[562],"adequate":[563],"particular":[567],"cohort,":[569],"particularly":[570],"histological":[573],"stage":[574],"fibrosis":[576],"1-2.":[579],"manifestations":[585],"patients.":[590],"To":[591],"explain":[592],"works,":[598],"treated":[602,623],"DPX2":[603],"cells,":[604],"HepG2":[609],"cell":[610],"line,":[611],"expresses":[613],"compared":[618],"cells":[622],"rifampicin,":[625],"High-dose":[629],"(200":[631],"\u03bcM)":[632],"activated":[633,747],"PXR;":[634],"GW4064":[636],"(3-30":[637],"\u03bcM),":[638],"(FXR)":[643],"agonist,":[644,696],"activity":[648,708],"to,":[650],"if":[651],"greater":[653],"than,":[654],"suggesting":[656],"FXR":[657,731],"involvement":[658],"regulation.":[661],"It":[662],"noteworthy":[664],"10":[668],"corresponds":[671],"plasma":[673],"concentration":[674,801],"400":[676],"mg/day":[677],"patients,":[680],"did":[681],"activate":[683],"PXR.":[684],"conclusion":[687],"based":[699],"P450":[702],"(CYP)3A4":[703],"RNA":[705],"(mRNA)":[706],"data":[709],"supratherapeutic":[711],"doses,":[712],"requires":[713],"more":[714,865,1020],"study.":[715],"Moreover,":[716],"possibility":[718],"coordinated":[720,808,822],"regulation":[721],"(LXR)":[737],"considered,":[741],"especially":[742],"can":[745],"variety":[750],"substrates,":[752],"troglitazone,11":[754],"PPAR-\u03b3":[756],"agonist.12":[757],"Reduction":[758],"TG":[760],"expected":[764],"action":[765,1046],"fibrates,":[767],"down-regulation":[772],"CYP7A1":[774],"CYP27A1":[776],"expression.":[777],"Interestingly,":[778],"Nakajima":[779],"showed":[782],"low-dose":[784],"TGs13":[787],"cholesterol14":[789],"PPAR-\u03b1-independent":[792],"mechanism,":[793],"supporting":[794],"notion":[796],"BF-mediated":[798],"actions":[799,809,823],"dependent":[802],"may":[804],"partially":[805],"occur":[806],"(i.e.":[812],"PPAR-\u03b4":[813],"and/or":[814],"LXR).":[818],"More":[819],"evidence":[820],"nuclear":[826],"receptors":[827],"finding":[830],"mRNA":[835],"PPAR\u03b1":[842],"independent":[843],"occurred":[845],"LXR.15":[847],"al.'s":[851],"begins":[853],"shed":[855],"light":[856],"molecular":[859],"behind":[861],"BF's":[862],"clinical":[863],"effects,":[864],"work":[866],"clearly":[868,998],"needed.":[869],"Lastly,":[870],"chenodeoxycholic":[876],"deoxycholic":[879],"and,":[881,1040],"lesser":[884],"extent,":[885],"cholic":[886],"lithocholic":[889],"acid,":[890],"attributed":[892],"inhibitory":[895],"effect":[896],"de":[900],"novo":[901],"bile-acid":[902,944],"synthesis;":[903],"one":[905],"could":[906],"argue":[907],"glucuronidation":[916],"UDP-glucuronosyltransferase":[920],"1A":[922],"2B":[924],"isoenzymes,":[925],"known":[926],"targets":[927,974],"LXR-\u03b1":[931],"agonists.16":[932],"Further":[933],"investigation":[934],"into":[935],"cholesterol":[941],"synthesis":[942],"metabolism":[945],"help":[947],"clarify":[949],"issue.":[951],"directly":[957],"coregulates":[958],"PPARs":[961],"remain,":[962],"benefits":[964],"using":[966],"drug,":[968],"such":[969],"multiple":[973],"regulate":[976],"bile-transporter":[977],"expression":[978],"inflammation,":[980],"seem":[986],"promising.":[987],"Larger,":[988],"multicenter,":[989],"prospective,":[990],"double-blind":[991],"plus":[995],"needed":[999],"recently":[1008],"noted":[1009],"others.17":[1011],"Fibrates":[1012],"tolerated":[1015],"there":[1018],"sufficient":[1022],"evidence,":[1023],"present":[1026],"al.,":[1031],"demonstrate":[1033],"possibly,":[1041],"PSC.":[1042],"modes":[1044],"within":[1047],"hepatocyte":[1049],"undoubtedly":[1051],"multifactorial":[1052],"likely":[1055],"account":[1057],"positive":[1060],"function.":[1064]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973298751","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
